Bejelentkezés Regisztrálj ingyen

Cellectis EPS Q/Q

Mi az Cellectis EPS Q/Q?

A EPS Q/Q az Cellectis - -52.27%

Mi a EPS Q/Q meghatározása?



A negyedévenkénti EPS negyedéves növekedési ráta az elmúlt 4 negyedévben a vállalat EPS-jének növekedése az előző 4 negyedév teljesítményéhez képest.

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q/Q a Health Care szektor a NASDAQ-on cégekben a Cellectis -hoz képest

Mit csinál Cellectis?

cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.

eps q/q -hoz hasonló cégek Cellectis